Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-10-022637)

Filing Details

Accession Number:: 0001209191-10-022637
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-04-16 13:00:00
Reporting Period:: 2010-04-14

Filing Date:: 2010-04-16
Accepted Time:: 2010-04-16 17:27:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1006281	Protalix Biotherapeutics Inc.	PLX	Biological Products, (No Disgnostic Substances) (2836)	650643773

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1385118	Yoseph Shaaltiel	C/O Protalix Biotherapeutics, Inc. 2 Snunit Street, Science Park, Pob 455 Carmiel L3 20100	Executive Vp, R&D	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-04-14	1,309	$7.00	882,445	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.